chartexchange

DSGN
Design Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:28:38 PM EST
9.32USD-1.531%(-0.15)164,094
9.2900Bid10.62Ask1.3300Spread

DSGN Financials

In Q3 FY 2026 (ended ), Design Therapeutics, Inc. Common Stock (DSGN) reported revenue of $0, net income of −$20.29M, operating cash flow of −$15.38M, and assets of $216.81M (filed ).

Loading financial statements…